OTCMKTS:EMMA Emmaus Life Sciences (EMMA) Stock Price, News & Analysis → Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (From Paradigm Press) (Ad) Free EMMA Stock Alerts $0.09 0.00 (0.00%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$0.09▼$0.0950-Day Range$0.09▼$0.1152-Week Range$0.05▼$0.28VolumeN/AAverage Volume5,667 shsMarket Capitalization$5.84 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Emmaus Life Sciences alerts: Email Address Ad Porter & CompanyTrump conviction scandal exposedIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. About Emmaus Life Sciences Stock (OTCMKTS:EMMA)Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. The company was founded in 2000 and is headquartered in Torrance, California.Read More EMMA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EMMA Stock News HeadlinesMay 28, 2024 | msn.comMSU students win Student Emmy for documentary about Dickerson Park Zoo medicineMay 26, 2024 | msn.comEmmaus' Moore rallies for second straight state long jump crownMay 9, 2024 | msn.comEmmaus boys lacrosse passes physical test from Central Catholic, moves on to EPC championshipMay 6, 2024 | msn.comWhen the eclipse illuminates: Emmaus sheds light on Erie poverty, possible solutionsMay 2, 2024 | yahoo.comEmmaus receives $250,000 Anderson grant for remodelingMay 2, 2024 | msn.comEmmaus boys lacrosse takes control in 2nd quarter, dominates rival ParklandApril 30, 2024 | yahoo.comDurham's Museum Of Life And Science Celebrates Birth Of 7 Endangered Red Wolf PupsApril 30, 2024 | msn.comEmmaus girls basketball coach Gallagher steps down after 7 seasonsApril 17, 2024 | msn.comDistrict 11 wrestling: Kinney, Fanelli, Smith earn Scholar-Athlete awardsApril 15, 2024 | finance.yahoo.comEmmaus Life Sciences Reports Delayed Filing of Annual ReportApril 10, 2024 | chicago.suntimes.comThe Museum of Science and Industry closed for mysterious reasons last week. Here’s whyApril 10, 2024 | investing.comEmmaus Life Sciences Inc (EMMA)April 4, 2024 | msn.comPeabody Museum Review: Smearing ScienceMarch 27, 2024 | wsj.comEmmaus Life Sciences Inc.February 24, 2024 | msn.comHomeless charity seeks volunteers to help with eBay operationsFebruary 23, 2024 | msn.comDiscovery World named one of the best science museums in USA Today's 10Best Readers' Choice AwardsFebruary 22, 2024 | msn.comTexas Tech University Health Sciences Center announces Simulation Program reaccreditationFebruary 18, 2024 | abcnews.go.comSaving democracy is central to Biden's campaign. Will it resonate with voters?February 2, 2024 | finance.yahoo.comEmmaus Life Sciences Receives Marketing Authorization for Puerto RicoFebruary 1, 2024 | msn.comScience Museum of Western Virginia announces grand opening of ‘The Eye’January 18, 2024 | msn.comEmmaus wrestlers roll their way over “flat” FreedomJanuary 17, 2024 | news.yahoo.comTransgender row at Science Museum over claims reworked exhibit is 'even more insidious'January 12, 2024 | msn.comBiden says Austin still has his confidence, but not revealing hospitalization was lapse in judgmentJanuary 8, 2024 | msn.comDenver Museum of Nature & Science gets makeover with East Wing renovation projectJanuary 4, 2024 | sfgate.comA local guide to science museums near San FranciscoSee More Headlines Receive EMMA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/16/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:EMMA CUSIPN/A CIK822370 Webwww.emmausmedical.com Phone(310) 214-0065Fax866-294-2611Employees54Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,620,000.00 Net Margins-16.66% Pretax Margin-16.42% Return on EquityN/A Return on Assets-9.73% Debt Debt-to-Equity RatioN/A Current Ratio0.15 Quick Ratio0.12 Sales & Book Value Annual Sales$18.39 million Price / Sales0.32 Cash FlowN/A Price / Cash FlowN/A Book Value($0.69) per share Price / Book-0.13Miscellaneous Outstanding Shares63,870,000Free Float41,513,000Market Cap$5.84 million OptionableNot Optionable Beta1.64 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Willis C. Lee M.S. (Age 64)Co-President, COO & Chairman of the Board Comp: $240kMr. Yasushi Nagasaki CPA (Age 57)CPA, Chief Financial Officer Comp: $250kMr. George Sekulich (Age 58)Co-President, Chief Commercial Officer & Director Mr. Dale E. Short J.D.Legal Consultant & Corporate SecretaryDr. Charles W. Stark Pharm.D (Age 69)Pharm.D., Senior Vice President of Medical Affairs, Clinical, Regulatory Mr. Kurt H. Kruger M.B.A. (Age 69)M.S., Consultant Comp: $300.02kMore ExecutivesKey CompetitorsAptorum GroupNASDAQ:APMMinerva NeurosciencesNASDAQ:NERVCytoMed TherapeuticsNASDAQ:GDTCVincerx PharmaNASDAQ:VINCBullfrog AINASDAQ:BFRGView All Competitors EMMA Stock Analysis - Frequently Asked Questions How have EMMA shares performed in 2024? Emmaus Life Sciences' stock was trading at $0.1001 on January 1st, 2024. Since then, EMMA stock has decreased by 8.7% and is now trading at $0.0914. View the best growth stocks for 2024 here. How do I buy shares of Emmaus Life Sciences? Shares of EMMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EMMA) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredA Silent Invasion of AmericaThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emmaus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emmaus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.